What zebrafish are teaching us about human disease
By Waasifa Ansari and R. Saptharishivel
Under the guidance of Dr. R. Sreeranjani and Dr. T. Sathyabama
Veterinary College and Research Institute, Namakkal, TANUVAS
Danio rerio grows to barely four centimetres, wears a set of horizontal blue stripes that gave it its common name, and spends its life in the shoals of India’s rivers and ponds — and, increasingly, in laboratory tanks stacked floor to ceiling in research institutes around the world. What makes this unassuming freshwater minnow indispensable to modern medicine is not its size but its transparency: for the first month of its life, a zebrafish embryo is essentially made of glass. Its organs form in plain view. Its heart begins to beat, its blood vessels branch outward, its brain wires itself into being — all of it visible under an ordinary microscope, without a single incision. That one biological accident, combined with a genome that shares roughly 70 per cent of its genes with ours, has turned zebrafish into one of the most consequential model organisms in contemporary biomedical research.
Why Not Just Use Mice?
The zebrafish’s case against the laboratory mouse rests on economics as much as biology. Adults are small, need little tank space, and cost a fraction of what it takes to house and feed a mouse colony. They breed roughly every ten days and can lay between 50 and 300 eggs in a single clutch — a fertility mice cannot match, producing as they do only one to ten pups per litter across a maximum of three litters in a lifetime. Because scientific findings gain credibility through repetition, an organism that produces more offspring, more often, is simply more useful to a working laboratory.
Zebrafish eggs are also fertilized externally, which means embryos can be manipulated from the moment of conception without ever touching the mother. A one-cell-stage egg can be injected directly with DNA or RNA to create transgenic or knockout lines — a procedure that, in mice, would require sacrificing the animal to access embryos developing inside the womb. Zebrafish larvae, transparent and only a few millimetres long between three and thirty days after fertilization, let scientists watch fluorescently labelled tissue develop in real time under a microscope, a window into vertebrate development that a mouse embryo, opaque and internal, simply cannot offer[1].
The model has its limits, however. Zebrafish cannot stand in for human diseases rooted in organs they simply do not possess — the prostate, the mammary gland, the lung — a caveat every researcher reaching for this fish has to keep in view.
Reading Disease through a Transparent Window
The basic experimental logic is elegant in its simplicity. A gene suspected of causing a disease in a human patient is sequenced, then “knocked out” in zebrafish to see whether losing its function reproduces the patient’s symptoms. Sometimes researchers go further and introduce the precise mutation itself — a “knock-in” — to study gene expression changes and disease development directly under the microscope. This has made zebrafish disease models a mainstay of drug discovery, prized in particular for high-throughput screening, where hundreds of embryos can be tested against candidate compounds far faster than any mammalian system would allow[2].
The Genetic Toolkit
What makes zebrafish genetics so productive is, again, that transparency. RNA in situ hybridization can map where and when a gene switches on across an entire embryo, and running two probes together — double in situ hybridization — reveals how different genes’ expression patterns relate to one another, a technique that has made zebrafish a workhorse for large-scale forward genetic screens. Precision editing tools — transcription activator-like effector nucleases (TALEN) and CRISPR-Cas systems — allow researchers to rewrite a specific genetic locus at will.
Older, blunter methods still have their place. In a now-classic experiment, the Driver and Fishman laboratories and the Nüsslein-Volhard laboratory treated adult male zebrafish with the mutagen N-ethyl-N-nitrosourea (ENU) to induce point mutations, then bred the fish to homozygosity to expose recessive phenotypes — a strategy that, over the years, has generated thousands of distinct mutant lines mirroring human disorders. Using plasmid vectors in these mutants, researchers can study erythrocyte development and circulatory defects, run in vivo tumour transplants, and track metastasis, angiogenesis, and drug response, all in a living, transparent animal[3].
The Weight of Evidence: Zebrafish and Metabolic Disease
Obesity research illustrates why zebrafish can succeed where whole-body physiology in larger mammals sometimes obscures the underlying biology. In humans, a wide range of compensatory responses — changes in appetite, metabolic rate, sympathetic activity — can mask what is actually happening at the level of the metabolic phenotype. Zebrafish express the leptin receptor and melanocortin-system proteins in the hypothalamus much as humans do; neuroactive peptides like ghrelin and agouti-related peptide stimulate feeding, while cocaine- and amphetamine-regulated transcript peptide, melanocortin, and corticotropin-releasing factor suppress it.
In humans, a mutation in the melanocortin-4 receptor (MC4R) causes obesity; what happens when MC4R is lost in zebrafish is not yet known, but over-expressing agouti-related peptide — which effectively opposes MC4R — produces obese fish marked by increased linear growth and enlarged fat cells. Fluorescent calcium indicators let researchers watch hypothalamic neurons fire in real time in mutant fish with altered appetite, while stains such as Oil Red O and Nile Red, which fluoresce in lipid-rich environments, make it possible to image the formation of fat cells as it happens, much as excess nutrients accumulate as lipid droplets in white adipose tissue in mammals generally[4].
Diabetes research draws on a similar structural resemblance. Long-term type 2 diabetes mellitus arises from insulin resistance and the failure of insulin-producing beta cells, and the zebrafish pancreas — its morphogenesis, its cellular architecture, its role in glucose homeostasis — is remarkably conserved with its mammalian counterpart, which makes the fish a natural tool for studying pancreatic disease. Overfeeding zebrafish commercial fish food for eight weeks reliably induces diet-related obesity and elevated blood glucose compared to normally fed fish, and these diabetic fish respond to the same anti-diabetic drugs used in humans — metformin and glimepiride both ease hyperglycemia and enhance insulin action by boosting glucose-transporter movement through AMP kinase activity.
The speed advantage here is dramatic: inducing hyperglycemia in mice or other lab mammals can take many weeks, but the same alterations appear in zebrafish within two days. Pancreatic regeneration studies add a further layer — cells from a diabetic zebrafish’s pancreas can be transplanted into a healthy fish and tracked, offering a live model of what researchers describe as a form of “glucose memory” carried at the cellular level[5].
Chasing Cancer, Cell by Cell
Cancer research is arguably where the zebrafish model has proved most versatile, spanning the development of human cancer models, the study of angiogenesis and metastasis, and the screening of small molecules for anti-cancer activity. Tumours can be induced in several ways — chemical mutagenesis, insertional mutagenesis, viral-vector mutagenesis, or simply adding carcinogens such as dibenzo(a,l)pyrene or N-nitrosodiethylamine to the water — or generated more directly, by microinjecting exogenous DNA into a one-cell-stage embryo or transplanting tumour cells outright[6].
Transplantation carries one persistent complication: immune rejection of the grafted tumour cells. Zebrafish embryos sidestep this problem neatly, since their immune system remains incompletely developed until roughly 21 days after fertilization, giving researchers a rejection-free window in which to work; adult fish, by contrast, need to be immunosuppressed with dexamethasone before a transplant will take. Once a tumour is established, researchers can watch it develop using fluorescent protein reporters, xenograft assays, 3D fluorescence imaging with lipophilic dyes, vertebrate automated screening technology that requires no gene transfer at all, and quantitative PCR performed ex vivo[7].
Angiogenesis — the growth of new blood vessels that keeps a tumour from starving itself of oxygen and gives cancer cells a route out of their tissue of origin — has been studied particularly closely in zebrafish. One influential study found that cancer cells engineered to express the metastasis gene RhoC travelled further from the transplantation site by exploiting contact with vascular endothelial growth factor (VEGF) to force their way into blood vessels, a process called intravasation; the same researchers, transplanting human cancer cells into the peritoneal cavity of immunosuppressed juvenile zebrafish, were able to observe the amoeboid movement and actin-myosin cytoskeletal changes that drive this behaviour directly[8].
The final act of metastasis — a cancer cell successfully colonizing a foreign tissue — has been dissected using a zebrafish model of KRASG12D-driven embryonal rhabdomyosarcoma, a muscle cancer of childhood. Tumour cells expressing the gene myf5 proved highly proliferative but barely migratory, while cells lacking the capacity to sustain a tumour on their own were nonetheless able to seed and grow at distant, secondary sites — a distinction that maps closely onto how real paediatric sarcomas spread[9,10].
Melanoma, driven in humans chiefly by BRAF and RAS mutations, has been modelled in zebrafish engineered to express green fluorescent protein under the crestin promoter: crestin marks neural crest cells in the embryo, and its re-expression in adult melanoma tumours mirrors what happens in human disease. A separate line of research has found that sex hormones shape the course of hepatocellular carcinoma in zebrafish, with males showing markedly higher mortality than females — a finding that echoes patterns long observed in human liver cancer[11].
Sentinel of the Waters: Zebrafish in Toxicology
Beyond disease modelling, zebrafish have become frontline instruments in environmental toxicology, particularly for detecting contamination in water samples. Transgenic fish engineered to express green fluorescent protein under a metal-responsive metallothionein promoter light up in the presence of heavy-metal exposure, giving researchers a visual readout of environmental toxin load. Gene-expression profiling across multiple platforms has also identified numerous chemical toxins that specifically damage the liver, producing effects ranging from necrosis and fatty liver to steatohepatitis and liver cancer.
In 2009, an international consortium of pharmaceutical companies developed a standardized zebrafish developmental assay to classify ten known teratogenic compounds against ten non-teratogenic ones. When the results were checked against existing mammalian toxicity data, the two systems agreed roughly 60 to 70 per cent of the time — respectable enough to establish zebrafish as a credible early-stage screening tool, if not a full replacement for mammalian testing[12].
Mapping the Mind: Zebrafish in Neuroscience
Zebrafish have also found a place in the study of brain disease, aided by methods ranging from targeted gene disruption to TALEN-based editing. The appeal here lies in the telencephalon, the zebrafish equivalent of the cerebral hemispheres, whose ventricular zone contains a neurogenic niche resembling mammalian brain progenitor cells — tissue that stays quiescent under normal conditions but can generate new neurons when injury demands it[13].
In autism spectrum disorder research, the glutamatergic NMDA-receptor antagonist MK-801 has become a standard tool for disrupting memory, behaviour, and cognitive function in zebrafish, producing reduced social preference and reduced aggression — effects that can be reversed by oxytocin and oxytocin-receptor activity, a finding with obvious relevance to the social deficits seen in human ASD[14].
Alzheimer’s disease has been modelled by injecting Aβ42 derivatives directly into the cerebral ventricles, producing symptoms that closely track the human disease: activation of ependymal tissue and enhanced neurogenesis driven by interleukin-4 signalling in neurons and microglia. These models give researchers a living platform on which to screen new therapeutics for their ability to reduce amyloid-β accumulation and the hyperphosphorylation associated with the disease[15].
Huntington’s disease, Parkinson’s disease, and schizophrenia have all found their way into zebrafish laboratories as well, each benefiting from the same transparent, fast-developing nervous system that has made this fish so useful across the rest of neuroscience[16].
The Road Ahead
Zebrafish are not mammals, and that non-mammalian status is precisely where their scientific value has always seemed most improbable — yet the striking conservation of disease-related genes and pathways between this small fish and ourselves has made the improbable into one of biomedicine’s more durable working relationships. As automation, patient-derived xenograft techniques, and fluorochrome-based imaging continue to advance, the model is only becoming more capable of tracking drug responses in a living animal, opening a faster route to preclinical cancer screening and, further down the line, to genuinely personalised therapy.
What remains is the harder, slower work of translation: understanding precisely how a drug interacts with a specific organ or tissue, so that what is learned in a four-millimetre fish can be carried, responsibly and reliably, into human medicine. The zebrafish has already proved it can show us the disease. The next chapter is proving it can show us the cure.
References
1. Lieschke, G. J., & Currie, P. D. (2007). Animal models of human disease: zebrafish swim into view. Nature Reviews Genetics, 8(5), 353–367.
2. Burke, E. (2016). Why Use Zebrafish to Study Human Diseases? Retrieved March 2017.
3. Veldman, M. B., & Lin, S. (2008). Zebrafish as a developmental model organism for pediatric research. Pediatric Research, 64(5), 470–476.
4. Seth, A., Stemple, D. L., & Barroso, I. (2013). The emerging use of zebrafish to model metabolic disease. Disease Models & Mechanisms, 6(5), 1080–1088.
5. Zang, L., Shimada, Y., & Nishimura, N. (2017). Development of a novel zebrafish model for type 2 diabetes mellitus. Scientific Reports, 7(1), 1461.
6. Zhao, S., Huang, J., & Ye, J. (2015). A fresh look at zebrafish from the perspective of cancer research. Journal of Experimental & Clinical Cancer Research, 34, 1–9.
7. Letrado, P., de Miguel, I., Lamberto, I., Díez-Martínez, R., & Oyarzabal, J. (2018). Zebrafish: speeding up the cancer drug discovery process. Cancer Research, 78(21), 6048–6058.
8. Stoletov, K., Montel, V., Lester, R. D., Gonias, S. L., & Klemke, R. (2007). High-resolution imaging of the dynamic tumor cell–vascular interface in transparent zebrafish.
Proceedings of the National Academy of Sciences, 104(44), 17406–17411.
9. Ignatius, M. S., Hayes, M. N., Moore, F. E., Tang, Q., Garcia, S. P., Blackburn, P. R., et al. (2018). tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish. eLife, 7, e37202.
10. Astell, K. R., & Sieger, D. (2020). Zebrafish in vivo models of cancer and metastasis. Cold Spring Harbor Perspectives in Medicine, 10(8).
11. Hason, M., & Bartůněk, P. (2019). Zebrafish models of cancer — new insights on modeling human cancer in a non-mammalian vertebrate. Genes, 10(11), 935.
12. Bambino, K., & Chu, J. (2017). Zebrafish in toxicology and environmental health. Current Topics in Developmental Biology, 124, 331–367.
13. Zambusi, A., & Ninkovic, J. (2020). Regeneration of the central nervous system — principles from brain regeneration in adult zebrafish. World Journal of Stem Cells, 12(1), 8.
14. Meshalkina, D. A., Kizlyk, M. N., Kysil, E. V., Collier, A. D., Echevarria, D. J., Abreu, M. S., et al. (2018). Zebrafish models of autism spectrum disorder. Experimental Neurology, 299, 207–216.
15. Best, J. D., & Alderton, W. K. (2008). Zebrafish: An in vivo model for the study of neurological diseases. Neuropsychiatric Disease and Treatment, 4(3), 567–576.
16. Saleem, S., & Kannan, R. R. (2022). Zebrafish: A Potential Preclinical Model for Neurological Research in Modern Biology. In Zebrafish Model for Biomedical Research (pp. 321–345). Singapore: Springer Nature Singapore.
